Center for Scientific Review; Notice of Closed Meeting, 65166 [2019-25593]
Download as PDF
<![CDATA[
65166
Federal Register / Vol. 84, No. 228 / Tuesday, November 26, 2019 / Notices
terms of points of view represented and
the committee’s function. Every effort is
made to ensure that diverse views and
perspectives are represented on HHS
Federal advisory committees and,
therefore, the Department encourages
nominations of qualified candidates of
all genders, cultural, ethnic, and racial
groups, people with disabilities, and
individuals who may belong to other
underrepresented groups. The
Department also seeks geographic
diversity in the composition of the
Committee. Appointment to this
Committee shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
disability, and cultural, religious, or
socioeconomic status. Requests for
reasonable accommodation to enable
participation on the Committee should
be indicated in the nomination
submission.
requirements met, disability
accommodation requests, and an
indication of commitment to attend
IACC meetings if selected, as well as full
contact information and a current
resume or curriculum vitae. Up to 2
letters of support are permitted in
addition to the nomination, with a page
limit of 3 pages per letter. Please do not
include other materials unless
requested.
Nominations are due by Friday
January 17, 2020 and may be sent to Dr.
Susan Daniels, Director, Office of
Autism Research Coordination/NIMH/
NIH, 6001 Executive Boulevard, Room
7220, Bethesda, Maryland 20892 by
standard or express mail, or via email to
IACCPublicInquiries@mail.nih.gov.
Confirmation of receipt will be
provided.
More information about the IACC is
available at iacc.hhs.gov.
Member Terms
Non-Federal public members of the
Committee ‘‘shall serve for a term of 4
years, and may be reappointed for one
additional 4-year term. Any member
appointed to fill a vacancy for an
unexpired term shall be appointed for
the remainder of such term. A member
[with a valid appointment] may serve
after the expiration of the member’s
term until a successor has been
appointed.’’
Dated: November 20, 2019.
Susan A. Daniels,
Director, Office of Autism Research
Coordination, National Institute of Mental
Health, National Institutes of Health.
Meetings and Travel
‘‘The Committee shall meet at the call
of the chairperson or upon the request
of the Secretary. The Committee shall
meet not fewer than 2 times each year.’’
In the years 2014–2019, the IACC held
an average of 4 meetings, 1 workshop
and 2 phone conferences per year,
including full committee,
subcommittee, working and planning
group meetings, and workshops. Travel
expenses are provided for non-federal
public Committee members to facilitate
attendance at in-person meetings.
Members are expected to be committed
to making every effort to attend all full
committee meetings and workshops in
person and relevant subcommittee,
working and planning group meetings
by phone. For those who occasionally
cannot travel or for individuals with a
disability that prevents travel, remote
access options are provided.
Submission Instructions and Deadline
Nominations should include a cover
letter of no longer than 3 pages
describing the candidate’s interest in
seeking appointment to the IACC,
including relevant personal and
professional experience with ASD,
indication of any membership eligibility
VerDate Sep<11>2014
16:47 Nov 25, 2019
Jkt 250001
[FR Doc. 2019–25668 Filed 11–25–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel RFA Panel:
Tobacco Regulatory Science C.
Date: December 19, 2019.
Time: 10:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kristen Prentice, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Health, 6701 Rockledge Drive, Room 3112,
MSC 7808, Bethesda, MD 20892, 301–496–
0726, prenticekj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 20, 2019
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–25593 Filed 11–25–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The invention listed below is
owned by an agency of the U.S.
Government and is available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Dianca Finch, Ph.D., 240–669–5503;
dianca.finch@nih.gov. Licensing
information and copies of the U.S.
patent application listed below may be
obtained by communicating with the
indicated licensing contact at the
Technology Transfer and Intellectual
Property Office, National Institute of
Allergy and Infectious Diseases, 5601
Fishers Lane, Rockville, MD, 20852; tel.
301–496–2644. A signed Confidential
Disclosure Agreement will be required
to receive copies of unpublished patent
applications.
SUPPLEMENTARY INFORMATION:
Technology description follows:
SUMMARY:
A High-Yield Perfusion-Based
Transient Gene Expression Bioprocess
Description of Technology
Currently, fed-batch processes are the
most commonly used bioprocesses in
transient gene expression (TGE) vaccine
manufacturing. However, because fedbatch processes keep all the cells and
protein product in the vessel throughout
the run, some limitations are intrinsic.
First, waste products like cell debris or
E:\FR\FM\26NON1.SGM
26NON1
]]>Agencies
[Federal Register Volume 84, Number 228 (Tuesday, November 26, 2019)]
[Notices]
[Page 65166]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25593]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel RFA Panel: Tobacco Regulatory Science C.
Date: December 19, 2019.
Time: 10:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kristen Prentice, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112, MSC 7808, Bethesda, MD
20892, 301-496-0726, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: November 20, 2019
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-25593 Filed 11-25-19; 8:45 am]
BILLING CODE 4140-01-P
